16 January 2017
News and Views
Links and Services
This month's Alimentary Pharmacology & Therapeutics investigates the cost and health consequences of treatment of primary biliary cirrhosis with ursodeoxycholic acid.
Long-term use of ursodeoxycholic acid is the recommended therapy in primary biliary cirrhosis.
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors